Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 15;8(4):716-723.
doi: 10.1016/j.synbio.2023.11.002. eCollection 2023 Dec.

Efficient production of 2'-fucosyllactose in unconventional yeast Yarrowia lipolytica

Affiliations

Efficient production of 2'-fucosyllactose in unconventional yeast Yarrowia lipolytica

Yan Zhang et al. Synth Syst Biotechnol. .

Abstract

2'-Fucosyllactose (2'-FL) has great application value as a nutritional component and the whole cell biosynthesis of 2'-FL has become the focus of current research. Yarrowia lipolytica has great potential in oligosaccharide synthesis and large-scale fermentation. In this study, systematic engineering of Y. lipolytica for efficient 2'-FL production was performed. By fusing different protein tags, the synthesis of 2'-FL was optimized and the ubiquitin tag was demonstrated to be the best choice to increase the 2'-FL production. By iterative integration of the related genes, increasing the precursor supply, and promoting NADPH regeneration, the 2'-FL synthesis was further improved. The final 2'-FL titer, 41.10 g/L, was obtained in the strain F5-1. Our work reports the highest 2'-FL production in Y. lipolytica, and demonstrates that Y. lipolytica is an efficient microbial chassis for the synthesis of oligosaccharides.

Keywords: 2′-Fucosyllactose; Iterative integration; NADPH regeneration; Pathway enhancement; Yarrowia lipolytica.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Effect of expression of FutC fused with different protein tags on 2′-FL titer. (A) Schematic digram of the 2′-FL biosynthetic pathway. (B) Effect of different protein tags on 2′-FL production. The data was derived from the results of three repeated experiments.
Fig. 2
Fig. 2
Enhanced 2′-FL production by iterative integration. (A) Plasmid construction for co-overexpression of Ub-hpFutC, klLAC12, maGMD and hpGMER. (B) 2′-FL production in strains obtained after the first, second, and third rounds of plasmid integration, respectively. The dashed line indicates the average level of 2′-FL production for each group of strains. The data was derived from the results of three repeated experiments.
Fig. 3
Fig. 3
Enhanced 2′-FL production by enhancing GDP-d-mannose synthesis pathway. (A) Schematic view of the strategies to strengthen GDP-d-mannose synthesis by co-overexpressing of PMI40, SEC53, and PSA1. (B) 2′-FL production of the strains F3-5 and the strain F4-2. (C) 2′-FL yield on glucose and 2′-FL titer (g/g DCW) of the strain F3-5 and the strain F4-2. The data was derived from the results of three repeated experiments. T-test was performed to determine p values. ***p < 0.001; ****p < 0.0001.
Fig. 4
Fig. 4
The enhancement of NADPH regeneration pathway promotes 2′-FL accumulation. (A) Schematic view of the enhanced NADPH regeneration pathway. (B) 2′-FL production and 2′-FL yield on glucose of the strains overexpressing ZWF1, PGL, and GND1, respectively. (C) 2′-FL titer of the strain F4-2 and the strain F5-1. (D) 2′-FL yield on glucose and OD600 of the strain F4-2 and the strain F5-1. The data was derived from the results of three repeated experiments. T-test was performed to determine p values. **p < 0.01; ***p < 0.001; ****p < 0.0001.
Fig. 5
Fig. 5
Biosynthesis of 2’ -FL by fed-batch fermentation. (A) Cell density (OD600), glucose concentration and lactose concentration in the culture medium during fermentation. (B) 2’ -FL production during fermentation.

References

    1. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012;22:1147–1162. - PMC - PubMed
    1. Eiwegger T., Stahl B., Schmitt J., Boehm G., Gerstmayr M., Pichler J., Dehlink E., Loibichler C., Urbanek R., Szepfalusi Z. Human milk--derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res. 2004;56:536–540. - PubMed
    1. Zuurveld M., van Witzenburg N.P., Garssen J., Folkerts G., Stahl B., Van't Land B., Willemsen L.E.M. Immunomodulation by human milk oligosaccharides: the potential role in prevention of allergic diseases. Front Immunol. 2020;11:801. - PMC - PubMed
    1. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:731–747. - PMC - PubMed
    1. Vandenplas Y., Berger B., Carnielli V.P., Ksiazyk J., Lagstrom H., Sanchez Luna M., Migacheva N., Mosselmans J.M., Picaud J.C., Possner M., Singhal A., Wabitsch M. Human milk oligosaccharides: 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) in infant formula. Nutrients. 2018;10 - PMC - PubMed

LinkOut - more resources